2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
- PMID: 24239923
- DOI: 10.1016/j.jacc.2013.11.002
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Erratum in
- J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):3024-3025
- J Am Coll Cardiol. 2015 Dec 22;66(24):2812
Keywords: ACC/AHA Practice Guideline; biomarkers, pharmacological; cardiovascular disease; cholesterol; diabetes mellitus; drug therapy; hydroxymethylglutaryl-CoA reductase inhibitors/statins; hypercholesterolemia; lipids; patient compliance; primary prevention; risk assessment; risk reduction behavior; secondary prevention.
Comment in
-
2013 ACC/AHA Guideline: a guideline for the population - without evidence from the population.Cardiovasc Drugs Ther. 2014 Jun;28(3):203-4. doi: 10.1007/s10557-014-6513-1. Cardiovasc Drugs Ther. 2014. PMID: 24610170 No abstract available.
-
Is myopathy the Achilles' heel of statins?: differences between the new cholesterol treatment guidelines and everyday clinical practice.J Am Coll Cardiol. 2014 Jun 3;63(21):2300-1. doi: 10.1016/j.jacc.2013.12.047. Epub 2014 Mar 5. J Am Coll Cardiol. 2014. PMID: 24613338 No abstract available.
-
Reply: is myopathy the achilles' heel of statins?: differences between the new cholesterol treatment guidelines and everyday clinical practice.J Am Coll Cardiol. 2014 Jun 3;63(21):2301. doi: 10.1016/j.jacc.2014.02.532. Epub 2014 Mar 5. J Am Coll Cardiol. 2014. PMID: 24613340 No abstract available.
-
Measurement of low-density lipoprotein cholesterol in assessment and management of cardiovascular disease risk.Clin Pharmacol Ther. 2014 Jul;96(1):20-2. doi: 10.1038/clpt.2014.69. Clin Pharmacol Ther. 2014. PMID: 24942398
-
Review of article: Statins: the good, the bad, and the unknown by Gordon H. Sun, MD, MS.J Vasc Nurs. 2014 Dec;32(4):156. doi: 10.1016/j.jvn.2014.10.001. Epub 2014 Nov 15. J Vasc Nurs. 2014. PMID: 25455322 No abstract available.
-
Navigating patient preference and guidelines as a fellow.J Am Coll Cardiol. 2015 Feb 3;65(4):398-400. doi: 10.1016/j.jacc.2014.12.006. J Am Coll Cardiol. 2015. PMID: 25634841 No abstract available.
-
Response: “Actually, it’s more of a guideline than a rule”.J Am Coll Cardiol. 2015 Feb 3;65(4):400. J Am Coll Cardiol. 2015. PMID: 25793247 No abstract available.
-
Low-density lipoprotein cholesterol goals: still not in patients' best interest.Evid Based Med. 2016 Aug;21(4):128-33. doi: 10.1136/ebmed-2016-110383. Epub 2016 Apr 5. Evid Based Med. 2016. PMID: 27048840 No abstract available.
Similar articles
-
2013 ACC/AHA Guideline: a guideline for the population - without evidence from the population.Cardiovasc Drugs Ther. 2014 Jun;28(3):203-4. doi: 10.1007/s10557-014-6513-1. Cardiovasc Drugs Ther. 2014. PMID: 24610170 No abstract available.
-
Is myopathy the Achilles' heel of statins?: differences between the new cholesterol treatment guidelines and everyday clinical practice.J Am Coll Cardiol. 2014 Jun 3;63(21):2300-1. doi: 10.1016/j.jacc.2013.12.047. Epub 2014 Mar 5. J Am Coll Cardiol. 2014. PMID: 24613338 No abstract available.
-
Reply: is myopathy the achilles' heel of statins?: differences between the new cholesterol treatment guidelines and everyday clinical practice.J Am Coll Cardiol. 2014 Jun 3;63(21):2301. doi: 10.1016/j.jacc.2014.02.532. Epub 2014 Mar 5. J Am Coll Cardiol. 2014. PMID: 24613340 No abstract available.
-
2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol: Primary Prevention.JAMA Cardiol. 2019 May 1;4(5):488-489. doi: 10.1001/jamacardio.2019.0777. JAMA Cardiol. 2019. PMID: 30969322 Review. No abstract available.
-
2013 ACC/AHA cholesterol treatment guideline: Paradigm shifts in managing atherosclerotic cardiovascular disease risk.Trends Cardiovasc Med. 2015 May;25(4):340-7. doi: 10.1016/j.tcm.2014.10.015. Epub 2014 Oct 28. Trends Cardiovasc Med. 2015. PMID: 25435519 Review.
Cited by
-
The impact of the cumulative burden of LDL-c and hs-CRP on cardiovascular risk: a prospective, population-based study.Aging (Albany NY). 2020 Jun 16;12(12):11990-12001. doi: 10.18632/aging.103365. Epub 2020 Jun 16. Aging (Albany NY). 2020. PMID: 32544081 Free PMC article.
-
Sex- and Gender-Based Pharmacological Response to Drugs.Pharmacol Rev. 2021 Apr;73(2):730-762. doi: 10.1124/pharmrev.120.000206. Pharmacol Rev. 2021. PMID: 33653873 Free PMC article.
-
Creatine kinase in the U.S. population: Impact of demographics, comorbidities, and body composition on the normal range.Medicine (Baltimore). 2016 Aug;95(33):e4344. doi: 10.1097/MD.0000000000004344. Medicine (Baltimore). 2016. PMID: 27537560 Free PMC article.
-
A Critical Analysis of the FDA's Omics-Driven Pharmacodynamic Biomarkers to Establish Biosimilarity.Pharmaceuticals (Basel). 2023 Nov 2;16(11):1556. doi: 10.3390/ph16111556. Pharmaceuticals (Basel). 2023. PMID: 38004421 Free PMC article. Review.
-
Distribution of lifespan gain from primary prevention intervention.Open Heart. 2016 Mar 11;3(1):e000343. doi: 10.1136/openhrt-2015-000343. eCollection 2016. Open Heart. 2016. PMID: 27042321 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical